The 2022 Canadian Cannabis Survey has provided important insights into Canadians' knowledge, attitudes and behaviours regarding cannabis use.
The Canadian government is collecting data to gain a better understanding of how Canadians perceive and use marijuana. This data will enable better monitoring of the national framework for controlling the production, distribution, sale, and possession of marijuana under the Cannabis Act.
Today, the Canadian Ministry of Health released the results of the 2022 Canadian Cannabis Survey. The Ministry has been conducting this survey annually since 2017, and the 2022 survey marks the sixth round of data collection, which took place from April to June.
The main findings of the 2022 Canadian cannabis study include:
The marijuana usage among teenagers aged 16-19 in the past 12 months has returned to pre-legalization levels in 2021 and 2022, after an increase between 2018 and 2020. Overall, the proportion of daily or almost daily users of marijuana among users, including teenagers aged 16-19 who have problematic or high-risk marijuana use, has remained steady since 2018. The percentage of people classified as "high risk" due to marijuana use has also remained stable since 2018. The proportion of respondents who smoked marijuana has continued to decline since 2018, while the proportion of those who used electronic pens to smoke marijuana has increased since 2021. Smoking marijuana remains the most common way of use, followed by ingestion and using electronic pens or e-cigarettes. Compared to 2021, a larger proportion of respondents reported that their usual marijuana source was from legal sources, with legal storefronts being the most common source since 2019. Compared to 2019, a smaller proportion of people reported illegal storefronts and illegal online sources in 2022. Among marijuana users, the number of people who drove after recent marijuana use decreased between 2018 and 2021 and remained the same in 2022. Over one-fourth of medical marijuana users reported using healthcare professionals' documentation, a proportion that has increased since 2021.
The results of the Canadian marijuana inquiry will be used to provide information for policy and plan development, as well as to assist in targeted public education and awareness campaigns. Survey data will also be helpful in providing information for legislative review of the marijuana bill, led by an independent panel of experts.
This significant survey adds to other national substance use surveys conducted by Health Canada, including the Canadian Alcohol and Drug Use Survey, as well as the Canadian Student Tobacco, Alcohol, and Drug Survey.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
